H.R. 6963 · 117th Congress
Accelerated Approval Integrity Act of 2022
- Stage
- In committee
- Sponsor
- Frank Pallone
- Introduced
- 2022-03-07
- Latest action
- 2022-03-08 · Referred to the Subcommittee on Health.
Summary
Accelerated Approval Integrity Act of 2022
This bill establishes requirements relating to postapproval studies for drugs that receive accelerated approval for serious or life-threatening diseases or conditions, such as requiring product sponsors to agree in advance to conduct such studies and terminating product approval if certain benchmarks are not met.